- Half Year 2020 4Basebio AG Earnings Call TranscriptAug 13, 2020Earnings
- Full Year 2019 4Basebio AG Earnings Call TranscriptApr 24, 2020Earnings
- Abcam PLC Abcam to Acquire Expedeon's Proteomics and Immunology Business - M&A Call TranscriptNov 11, 2019
- Q2 2019 Expedeon AG Earnings Call (German) TranscriptAug 14, 2019Earnings
- Full Year 2018 Expedeon AG Earnings Call TranscriptApr 25, 2019Earnings
Q2 2019 Expedeon AG Earnings Call (German) Transcript
Thank you very much, Kevin, and welcome, everybody, to our half yearly conference call where we're going to report to you about the progress we've made in the first half of 2019.
As mentioned today on the call, there's myself, Heikki Lanckriet, CEO; and I've got David Roth, our CFO in the room as well. Before we start off -- before we start off, the usual disclaimer. So I'll give you a quick minute to read this. And then we can move on to today's agenda.
So I will give you a quick company overview and a brief operational review. I won't go into too much detail because I want to give as much time as possible to David to go into the financial details of the half yearly report, and then we'll finish off with an outlook for the rest of the year.
So starting off then with the company review. For those of you who have been following us for a few years now, you've seen that we've gone through quite a transition where we've been executing our grow, buy, build strategy. So over the past 3
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)